NEWS

April 22, 2026

HealthCare Royalty Announces Royalty Monetization Agreement for Modeyso® Commercial Royalties

April 6, 2026

Apnimed Secures Up to $150 Million in Debt Financing with HealthCare Royalty Partners to Support Planned AD109 Commercial Launch

April 2, 2026

Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

March 3, 2026

Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

October 31, 2025

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth

August 7, 2025

Duke Professor Reinvests Royalties into New Research

July 30, 2025

KKR Announces Strategic Acquisition of HealthCare Royalty Partners, Expanding the Firm’s Health Care Franchise and Enhancing its Life Sciences Strategy

June 30, 2025

BridgeBio Raises $300 Million Through Partial Capped Monetization of BEYONTTRA® European Royalty

May 19, 2025

REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million

March 18, 2025

Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million